Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
3Y CAGR+141.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+141.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
14.1x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.96M | +1.3% |
| 2024 | $15.76M | +32.0% |
| 2023 | $11.95M | +958.0% |
| 2022 | $1.13M | +5031.8% |
| 2021 | $22000.00 | +100.2% |
| 2020 | $-9.65M | -1577.5% |
| 2019 | $653000.00 | +198.9% |
| 2018 | $-660000.00 | -107.2% |
| 2017 | $9.13M | - |